Nov 15 (Reuters) - UCB SA : * The Lancet publishes first head-to-head study of Cimzia (certolizumab pegol) and Humira (adalimumab) in bio-naïve rheumatoid arthritis patients Sign up here. * Study did ...
BRUSSELS, June 26 (Reuters) - Europe's drug watchdog has recommended EU approval of UCB SA's Cimzia drug as a treatment for rheumatoid arthritis, the Belgian company said on Friday, clearing the way ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results